Poland – Antineoplastic agents – Zakup i sukcesywna dostawa leków z programów lekowych.
Opportunity Score
Confidence: 35%
Complexity: medium
14 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open tender by Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie for successive delivery of antineoplastic drugs (programmed drugs) divided into 4 parts (lots). Only Part 1 has detailed description (Avelumabum/Amivantamabum). Other lots lack titles and descriptions in structured data. Procedure is open, electronic submission required, language Polish. No estimated value provided. Bid deadline: 2026-06-29 07:00 UTC.
Strengths
Documents available
Open procedure
Medium complexity
Risks
Submission deadline in 14 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission via platform Open portal
- Bid must be in Polish.
- Bid validity: 90 days (until 26.09.2026).
Buyer
Name
Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
Location
Rzeszów, POL
Website
Buyer profile
Identifier
NIP: 8132919313
Lots (4)
Supply of Amivantamabum (solution for injection 1600 mg/10 ml, 240 mg/14 ml; concentrate for infusion 350 mg/7 ml) for 12 months. No variants allowed.
No description provided. Expected to be supply of antineoplastic agents similar to Part 1 but details are missing from structured data.
No description provided. Expected to be supply of antineoplastic agents similar to Part 1 but details are missing from structured data.
Procurement Details
Publication
26 May 2026
Deadline
29 Jun 2026, 07:00
Procedure
open
Contract
supplies
Duration
12 MONTH
Language
POL
Publication #
358939-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 35%
Complexity: medium
14 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation